{"schema_version":"secwatch.filing_event.v1","accession":"0002031090-25-000015","form_type":"8-K","ticker":"PRA","cik":"0001127703","company_name":"PROASSURANCE CORP","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.400261+00:00","generated_at":"2026-05-17T20:27:01.735682+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ProAssurance reports Q2 net income $21.9M ($0.42 EPS); merger with Doctors Co. on track","bullets":["Net income $21.9M ($0.42 diluted EPS); operating income $26.8M ($0.52 diluted EPS) for Q2 2025.","Specialty P&C net premiums written stable at $135.9M; renewal premium increases of 10% (cumulative >70% since 2018).","Non-GAAP combined ratio improved 9.5 ppts YoY; net investment income up 6%.","Book value per share $24.80, up $1.31 from year-end; adjusted book value $27.07.","Stockholders approved merger with The Doctors Company; FTC granted early termination; expected close H1 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0002031090-25-000015","json":"https://secwatch.observer/filing/0002031090-25-000015.json","markdown":"https://secwatch.observer/filing/0002031090-25-000015.md","text":"https://secwatch.observer/filing/0002031090-25-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1127703/000203109025000015/0002031090-25-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1127703/000203109025000015/pra-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:27:01.735682+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}